Form 4: iRhythm CFO Wilson Reports RSU Vesting, Tax-Related Stock Sale
Insider Transaction Report
iRhythm Holdings, Inc.'s Chief Financial Officer, Daniel G. Wilson, reported the acquisition of shares from vested performance RSUs and a subsequent sale to cover tax obligations.
Summary
- Daniel G. Wilson, Chief Financial Officer of iRhythm Holdings, Inc., acquired 9,412 shares of common stock on February 24, 2026, at a price of $0.
- These shares were acquired upon the determination that performance conditions were met with respect to performance Restricted Stock Units (RSUs) granted to Mr. Wilson on February 27, 2023.
- On February 25, 2026, Mr. Wilson disposed of 5,188 shares of common stock at a price of $135.4189 per share.
- This disposition was made to cover tax withholding and remittance obligations in connection with the vesting of the performance RSUs.
- Following these transactions, Mr. Wilson directly beneficially owns 30,694 shares and indirectly owns 100 shares through a family trust, totaling 30,794 shares.
- On January 12, 2026, iRhythm Holdings, Inc. completed a holding company reorganization, becoming the successor issuer to iRhythm Technologies, Inc., with all outstanding shares and equity awards converting on a one-for-one basis.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral to slightly positive event. The vesting of performance RSUs indicates the achievement of performance targets, which is positive, but the transaction itself is routine for insider compensation and tax management.
Positives
- Performance conditions for the Restricted Stock Units (RSUs) granted in February 2023 were met, indicating successful achievement of company or individual goals.
- The vesting of RSUs represents a form of long-term incentive compensation for the Chief Financial Officer, aligning management interests with shareholder value.
Negatives
- A portion of the acquired shares (5,188 shares) was sold to cover tax obligations, which is a common practice but reduces the direct ownership stake.
Future Outlook
The filing does not contain specific forward-looking statements or guidance regarding the company's future performance or strategic direction, beyond the completion of the holding company reorganization.
Industry Context
StockSavvy.ai notes that Form 4 filings are routine disclosures for corporate insiders, reflecting changes in their beneficial ownership. The reported RSU vesting and subsequent tax-related sale are standard practices for executive compensation, aligning with common industry trends where performance-based equity awards are a significant component of executive pay packages. The holding company reorganization is a structural change that typically does not impact the operational business or proportionate ownership interests.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Holding Company Reorganization | iRhythm Holdings, Inc. became the successor issuer to iRhythm Technologies, Inc. pursuant to Rule 12g-3(a) of the Securities Exchange Act of 1934. | 2026-01-12 | This structural change resulted in a one-for-one conversion of outstanding shares and equity awards, with no change to the proportionate interests of security holders, indicating a largely administrative impact on corporate governance structure rather than a substantive policy shift. |
Related Party Transactions
- Daniel G. Wilson indirectly holds 100 shares through The Wilson Living Trust dated July 9, 2015, of which he is the Trustee. This represents a related party ownership structure.
Stakeholder Impact
- Shareholders: The vesting of performance RSUs suggests that company performance targets were met, which could be viewed positively. The tax-related sale is a routine event and does not typically signal a change in management's long-term view of the company.
- Employees: The RSU vesting demonstrates the company's commitment to performance-based compensation, which can be a positive for employee morale and retention, particularly for executives.
Key Dates
| Date | Description |
|---|---|
| 2015-07-09 | Date of The Wilson Living Trust, through which Mr. Wilson indirectly holds shares. |
| 2023-02-27 | Date performance Restricted Stock Units (RSUs) were granted to Daniel G. Wilson. |
| 2026-01-12 | Effective date of the holding company reorganization where iRhythm Holdings, Inc. became the successor issuer to iRhythm Technologies, Inc. |
| 2026-02-24 | Date of acquisition of 9,412 shares of common stock upon RSU vesting. |
| 2026-02-25 | Date of disposition of 5,188 shares of common stock to cover tax obligations. |
| 2026-02-26 | Date the Form 4 was signed by the attorney-in-fact. |
Recommendation
holdThis Form 4 filing details routine insider transactions related to equity compensation and tax obligations, along with a previously announced holding company reorganization. It does not provide new material information about the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. The RSU vesting is a positive indicator of past performance, but the overall impact on future stock performance is neutral, thus a 'hold' recommendation is appropriate.
Keywords
iRhythm Holdings, IRTC, Form 4, Insider Trading, Stock Transaction, CFO, Daniel G. Wilson, Restricted Stock Units, RSU Vesting, Tax Sale, Equity Compensation, Holding Company Reorganization
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.